Meeting the challenge: prevention of pneumococcal disease with conjugate vaccines

Meeting the challenge: prevention of pneumococcal disease with conjugate vaccines

Streptococcus pneumoniae is one of the leading causes of both invasive and noninvasive diseases in the pediatric population and continues to represent a significant public health burden worldwide. The increasing incidence of antibioticresistant strains of the pathogen has complicated treatment and m...

Full description

Bibliographic Details
Main Authors:	Echániz-Avilés Irma Gabriela, Solórzano-Santos Fortino
Format:	Article
Language:	English
Published:	Instituto Nacional de Salud Pública 2001-01-01
Series:	Salud Pública de México
Subjects:	pneumococcal infections Streptococcus pneumoniae infant vaccines
Online Access:	http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342001000400012

Similar Items

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
by: Andrew D. Wiese, et al.
Published: (2019-04-01)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Adult pneumococcal vaccination – new opportunities
by: ERNEST KUCHAR, et al.
Published: (2023-03-01)

Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq
by: Al-Jumaili A, et al.
Published: (2023-05-01)

Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe
by: Germaine Hanquet, et al.
Published: (2022-01-01)

Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain
by: I. Rivero-Calle, et al.
Published: (2020-06-01)

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey
by: Ahmet Arvas, et al.
Published: (2017-08-01)

Eventos adversos após vacinação contra o pneumococo Adverse events after pneumococcal vaccination
by: Maria Rita Donalisio, et al.
Published: (2007-02-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
by: A. L. Perova, et al.
Published: (2014-09-01)

Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in Korea and Hong Kong
by: Salini Mohanty, et al.
Published: (2022-11-01)

Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis
by: Kaile Chen, et al.
Published: (2018-06-01)

Preventive Efficacy of Pneumococcal Conjugated Vaccine (Population Aspects)
by: I. N. Protasova, et al.
Published: (2022-01-01)

The Results of a Three-Year Pneumococcal Vaccination of Children in Russia
by: Nikolay I. Briko, et al.
Published: (2018-10-01)

Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine
by: Matt Wasserman, et al.
Published: (2018-01-01)

Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults
by: Lucila Rey-Ares, et al.
Published: (2024-05-01)

STREPTOCOCCUS PNEUMONIAE SEROTYPE DISTRIBUTION AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINES
by: Mariya Malcheva
Published: (2019-06-01)

Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children
by: Sabelle Jallow, et al.
Published: (2017-05-01)

Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
by: Michael Pichichero, et al.
Published: (2023-12-01)

Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines
by: Qian-qian Du, et al.
Published: (2021-12-01)

Approaches to vaccination of adults against pneumococcal disease in different countries of the world
by: A. S. Korovkin, et al.
Published: (2024-07-01)

Vaccine effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease: a systematic search and meta-analysis
by: Melina Gade Sikjær, et al.
Published: (2023-01-01)

Cost-effectiveness analysis of domestic 13-valent pneumococcal conjugate vaccine for children under 5 years of age in mainland China
by: Caixia Wang, et al.
Published: (2021-07-01)

Analysis of pneumococcal serotypes distribution to determine a model composition for a Russian pneumococcal conjugate vaccine
by: V. P. Trukhin, et al.
Published: (2022-07-01)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
by: Lucía Fernández-Delgado, et al.
Published: (2021-10-01)

Molecular characteristics and antimicrobial resistance of invasive pneumococcal isolates from children in the post-13-valent pneumococcal conjugate vaccine era in Shenzhen, China
by: Lu Huang, et al.
Published: (2024-03-01)

Cost-utility analysis of a universal pneumococcal vaccination programme for older adults in Norway
by: Liv Solvår Nymark, et al.
Published: (2022-11-01)

Recent progress in pneumococcal protein vaccines
by: Sha Li, et al.
Published: (2023-09-01)

Effect of 10-valent pneumococcal conjugate vaccine on trends of pneumococcal meningitis in children under five years, Uganda, 2003–2022
by: Yasiini Nuwamanya, et al.
Published: (2024-10-01)

A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age
by: Brandon Essink, et al.
Published: (2021-08-01)

An adult case of invasive pneumococcal disease due to serotype 12F-specific polysaccharide antibody failure following a 23-valent polysaccharide vaccination
by: Yasuhiro Tanaka, et al.
Published: (2020-01-01)

Increased Invasive Pneumococcal Disease, North East England, UK
by: Catherine Houseman, et al.
Published: (2017-01-01)

Pediatric parapneumonic effusion before and after national pneumococcal vaccination programs in Taiwan
by: Jun Yi Sim, et al.
Published: (2020-11-01)

Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines
by: Ninecia R. Scott, et al.
Published: (2021-03-01)

Streptococcus pneumoniae serotype 19A in hospitalized children with invasive pneumococcal disease after the introduction of conjugated vaccines in Lima, Peru
by: Theresa J. Ochoa, et al.
Published: (2024-01-01)

Antimicrobial Resistance in <i>Streptococcus pneumoniae</i> before and after the Introduction of Pneumococcal Conjugate Vaccines in Brazil: A Systematic Review
by: Patricia Alice Knupp-Pereira, et al.
Published: (2024-01-01)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
by: Nobuhiro Asai, et al.
Published: (2021-11-01)

Increase of Macrolide-Resistance in Streptococcus pneumoniae Strains After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Lima, Peru
by: Brayan E. Gonzales, et al.
Published: (2022-05-01)

Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016–2018—The ECAPS study
by: Karin Hansen, et al.
Published: (2023-02-01)

Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
by: Cornelis H. van Werkhoven
Published: (2017-05-01)

Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary <i>Streptococcus pneumoniae</i> Challenge during Influenza A Infection
by: Sean Roberts, et al.
Published: (2019-10-01)